INSM1 and neuroendocrine carcinoma: The second-generation neuroendocrine markers insulinoma-associated protein 1 (INSM1), ISL1, and secretagogin, have high sensitivity and specificity for neuroendocrine differentiation, expressed even in poorly differentiated neuroendocrine carcinomas [148,149,150].